-
Registration:
-
CME Information or Content Source:This activity has been planned and implemented in accordance with the Essential Areas and policies of the Medical Society of Virginia through the joint providership with Carilion Clinic’s CME Program and OncoLens. Carilion Clinic’s CME Program is accredited by The Medical Society of Virginia to provide continuing medical education for physicians. Carilion Clinic’s CME Program designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
-
Event Sponsor(s):This activity is supported by an educational grant from Pfizer
-
Expires:May 20, 2023
Course Description
Please join us for a 3-part, CME, virtual webinar series featuring expert discussion of Aplastic Anemia, hosted by Carilion Clinic.
SPEAKER:
Dr. William Fintel, MD
Medical Director, Carilion Clinic
MODERATOR:
Dr. Apostolos Dallas, MD
Associate Professor, Internal Medicine, Virginia Tech Carilion School of Medicine
CME Director, Carilion Clinic
SPEAKER:
Dr. Brant Ward, MD, PhD
Assistant Professor of Medicine, Virgina Commonwealth University
MODERATOR:
Dr. Darian Wang, MD
Residency Associate Program Director, Virginia Tech Carilion School of Medicine
SPEAKER:
Dr. Elizabeth Krieger, MD
Hematology and Oncology, Virgina Commonwealth University
MODERATOR:
Dr. Darian Wang, MD
Residency Associate Program Director, Virginia Tech Carilion School of Medicine
Overall Learning Objectives
Following the educational activities, participants will be able to:
- Improve the care of patients through early identification and diagnosis of Aplastic Anemia.
- Have increased awareness of Aplastic Anemia to refer patients to higher clinical centers of reference
- Understand and implement current standards for the treatment for Aplastic Anemia and its complications.
- Standardize the clinical management of special patient subpopulations and difficult cases of Aplastic Anemia patients.
Learning Objectives — May 4th Session
- Recognize three general categories of pancytopenia: Normocellular marrow, Hypercellular marrow, Hypocellular marrow.
- Recognize the Myriad of treatment options, all dependent on a correct diagnosis, to help steer and treat your patient.
Learning Objectives — May 12th Session
- Describe the primary and secondary causes of bone marrow aplasia.
- Identify inherited causes of bone marrow failure.
- Apply features of inherited immune disorders to the pathogenesis of bone marrow aplasia.
Learning Objectives — May 19th Session
- Analyze the genetic predispositions that can lead to bone marrow aplasia
- Evaluate the genetic causes of bone marrow aplasia that necessitate modified treatment approaches
- Comprehend the dynamic landscape of immunosuppressive therapy for the management of aplastic anemia
- Examine the role of transplantation as a potential curative treatment option for aplastic anemia
- Discuss current and emerging clinical trials exploring novel treatment strategies for aplastic anemia.
Target Audience
Internal Medicine providers, Hematologists, Medical Oncologists, Pathologists, Primary Care Physicians, Nurses, Mid-Level Providers, Residents, Fellows, and any other members of the hematology care team.
Identification and Mitigation of Disclosure of Financial Relationships
Planning Committee: Dr. Paul Dallas, Dr. William Fintel, Hien Thach, RN, and Linda Wells, CHCP reported no relevant relationships/affiliations with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.
Latest
